Subsequent event	12 Months Ended
Dec. 31, 2013
Subsequent Event [Abstract]
Subsequent event	12. Subsequent event: On February 7, 2014, the Company entered into subscription agreements (the "Subscription Agreements") with certain investors (each, an "Investor," and, collectively, the "Investors"). Under the terms of the Subscription Agreements, the Investors purchased an aggregate of 260 Units (each a "Unit," and, collectively, the "Units") at a purchase price of $3.00 per Unit for an aggregate purchase price of approximately $780. Each Unit consists of two (2) shares of the Company's Series D-1 Preferred Stock and one (1) share of Series D-2 Preferred Stock. The Series D-1 Preferred Stock and Series D-2 Preferred Stock are identical in rights, preferences, and privileges, except for their conversion price to Common Stock. Shares of Series D-1 Preferred Stock are convertible into shares of Common Stock at an initial conversion price of $0.0225 per share (subject to certain anti-dilution adjustment). Shares of Series D-2 Preferred Stock are convertible into shares of Common Stock at an initial conversion price of $0.05 per share (subject to certain anti-dilution adjustment). The Investors were also issued warrants to purchase approximately 7.091 million shares of Common Stock at the time of the funding of their investment. These warrants are exercisable for a period of three years and have an exercise price of $0.0275 per share. In addition to the warrants issued at closing, the Subscription Agreements entitle Investors to receive warrants to purchase up to an additional 21.273 million shares of Common Stock based on whether the Company attains certain revenue targets in 2014., as discussed in Note 9. Any such additional warrants will be exercisable until December 31, 2016 and will have an exercise price of $0.0275 per share.

Subsequent event

12 Months Ended

Dec. 31, 2013

12. Subsequent event:

On February 7, 2014, the Company entered into subscription agreements (the "Subscription Agreements") with certain investors (each, an "Investor," and, collectively, the "Investors"). Under the terms of the Subscription Agreements, the Investors purchased an aggregate of 260 Units (each a "Unit," and, collectively, the "Units") at a purchase price of $3.00 per Unit for an aggregate purchase price of approximately $780. Each Unit consists of two (2) shares of the Company's Series D-1 Preferred Stock and one (1) share of Series D-2 Preferred Stock. The Series D-1 Preferred Stock and Series D-2 Preferred Stock are identical in rights, preferences, and privileges, except for their conversion price to Common Stock. Shares of Series D-1 Preferred Stock are convertible into shares of Common Stock at an initial conversion price of $0.0225 per share (subject to certain anti-dilution adjustment). Shares of Series D-2 Preferred Stock are convertible into shares of Common Stock at an initial conversion price of $0.05 per share (subject to certain anti-dilution adjustment).

The Investors were also issued warrants to purchase approximately 7.091 million shares of Common Stock at the time of the funding of their investment. These warrants are exercisable for a period of three years and have an exercise price of $0.0275 per share. In addition to the warrants issued at closing, the Subscription Agreements entitle Investors to receive warrants to purchase up to an additional 21.273 million shares of Common Stock based on whether the Company attains certain revenue targets in 2014., as discussed in Note 9. Any such additional warrants will be exercisable until December 31, 2016 and will have an exercise price of $0.0275 per share.